Early-stage drug-discovery contract research organization (CRO) providing biochemical, cell-based, biophysical, in vivo pharmacology, immuno-oncology, safety, and biomarker assay services, with particular expertise in kinase and epigenetic drug targets
Early-stage drug-discovery contract research organization (CRO) providing biochemical, cell-based, biophysical, in vivo pharmacology, immuno-oncology, safety, and biomarker assay services, with particular expertise in kinase and epigenetic drug targets. Also offers research products, protein production, and assay development to pharmaceutical, biotech, academic, and government customers.